Results

Total Results: 1,187 records

Showing results for "week".

  1. Autism Surveillance (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_surveillance.pdf
    October 01, 2012 - RCT of a less intensive DIR-based developmental social pragmatic (DSP) intervention (2 hours per week … children w ASD and anxiety-related issues, aged 9 to 16 years One 90 minute group session per week … at the center; 10h/week at home Children receiving EIBI showed improvements in autism severity, … ABA program Intensity: Two 30 minute sessions per week, for 12 weeks Tx group had greater play … in class, 4 hours per week individual service 31% of children entering with ASD were functioning
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
    January 09, 2020 - ; 1 week to <2 weeks; 2 weeks to 4 weeks? … satisfaction, and quality of life after follow-up at the following intervals: < 1 day; 1 day to <1 week … ; 1 week to <2 weeks; 2 weeks to 4 weeks? … ; 1 week to <2 weeks; 2 weeks to 4 weeks? … ; 1 week to <2 weeks; 2 weeks to 4 weeks None 7 PICOTS Elements Inclusion Criteria
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
    May 01, 2022 - tapentadol in pain at 1 day to <1 week, 1 to <2 weeks, or ≥4 weeks. … ; 1 week to less than 2 weeks; 2 weeks to less than 4 weeks; 4 weeks or longer? … ; 1 week to <2 weeks; 2 weeks to less than 4 weeks; 4 weeks or longer? … ; 1 week to less than 2 weeks; 2 weeks to less than 4 weeks; 4 weeks or longer? … ; 1 week to less than 2 weeks; 2 weeks to less than 4 weeks; 4 weeks or longer?
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary_0.pdf
    September 01, 2021 - corticosteroid injection for piriformis syndrome may be similarly effective versus sham for pain at 1 week … with large reductions in pain and moderate to large improvement in function versus usual care at 1 week … No trial compared kyphoplasty against sham (SOE: low for function at 1 week; moderate for pain and … piriformis syndrome associated with no difference versus local anesthetic alone in pain at rest at 1 week … moderate reduction in pain at rest versus local anesthetic at 1 month (SOE: low for no difference at 1 week
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-social-isolation-older-adults-final.pdf
    February 01, 2019 - four interventions that found a positive effect on health or social isolation met more than once per week … Of the same four studies, three were high intensity, meeting more than once a week. … ), and two were medium-low intensity (met less than once a week or once a week, depending on intervention … vs. twice a week). … Attended 4-5 meetings, for 1 hour roughly every third week.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-appendix-b.xlsx
    May 29, 2025 - Usual care: Approximately 20 to 25 hours of treatment per week including individual and group therapy … provide service delivery methods that offer more convenience and less burden Duration: Varied Followup: Week … 6, Week 12, Week 24 Baseline variables, facility (long vs. short-term), substance use Days drank alcohol … Targeted discharge planning (16 week period) B. … No targeted discharge planning (previous 16 week period) A.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-3-acute-pain.pdf
    June 01, 2022 - tapentadol in pain at 1 day to <1 week, 1 to <2 weeks, or ≥4 weeks. … sham TENS at 1 day to <1 week. … no difference at 1 day to <1 week (SOE: low, based on 12 RCTs [<1 day] and 3 RCTs [1 day to <1 week … ; 1 week to less than 2 weeks; 2 weeks to less than 4 weeks; 4 weeks or longer? … ; 1 week to <2 weeks; 2 weeks to less than 4 weeks; 4 weeks or longer?
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
    January 01, 2023 - B Mean mg/week at 3 month followup THC: 93.29 (SD 228.12) vs. … B Pain intensity index (VAS 0-100 scale) mean relative change (improvement) rates at week 24 83.4% vs … B Pain-related disabilities (VAS 0-100 scale) mean relative change (improvement) rates at week 24 76.0% … B Physical quality of life (VR12-PCS; NRS 100 scale) mean relative change (improvement) rates at week … Anxiety (DASS-A; NRS21) mean relative change (improvement) rates at week 24 78.4% vs. 52.3%, p<0.001
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
    January 01, 2022 - B Mean mg/week at 3 month followup THC: 93.29 (SD 228.12) vs. … B Pain intensity index (VAS 0-100 scale) mean relative change (improvement) rates at week 24 83.4% vs … B Pain-related disabilities (VAS 0-100 scale) mean relative change (improvement) rates at week 24 76.0% … B Physical quality of life (VR12-PCS; NRS 100 scale) mean relative change (improvement) rates at week … Anxiety (DASS-A; NRS21) mean relative change (improvement) rates at week 24 78.4% vs. 52.3%, p<0.001
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
    January 01, 2020 - use the platform at a research or clinical facility required them to attend sessions 1-5 days per week … ) Gusi, 200621 Barefoot Not reported 3 days per week, at least 1 day of rest in between sessions … ) Rubin, 200430 Unknown Yes 7 days per week 48 No No bone medications at start No 48 Russo … , 200352 Not reported Not reported 2 days per week 24 No Not reported if medications taken Yes … 8 No No bone medications at start No 8 Ezenwa, 200873 Not reported Yes 3 times per week 20
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
    April 01, 2013 - One other trial of 24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa … Among patients randomized to the 24-week telaprevir regimen, one to two-thirds experienced a rash ( … 4 SVR, HCV RNA seronegative by PCR throughout 24-week off-treatment period Safety - adverse event … Versus 48-Week Courses of Peginterferon Plus. … Boceprevir Pegylated interferon alfa-2b Ribavirin Adult Senior Efficacy Week 8 response Week
  12. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
    December 01, 2015 - Original Search Strategy Database: Ovid MEDLINE(R) and Ovid OLDMEDLINE(R) <1946 to June Week 4 2015 … telaprevir vs. 12 week teleprevir regimen: •! … Higher BMI 24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa-2b, and … telaprevir vs. 12 week teleprevir regimen: •! … alfa-2b (1.5 µg/kg/week; n=259) with ribavirin (800–1200 •!
  13. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
    December 01, 2015 - Original Search Strategy Database: Ovid MEDLINE(R) and Ovid OLDMEDLINE(R) <1946 to June Week 4 2015 … telaprevir vs. 12 week teleprevir regimen: •! … Higher BMI 24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa-2b, and … telaprevir vs. 12 week teleprevir regimen: •! … alfa-2b (1.5 µg/kg/week; n=259) with ribavirin (800–1200 •!
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d2.xlsx
    January 01, 2024 - avoid potential excessive acute toxic effects in the hypofractionation group, only three fractions per week … Patients received five daily fractions of 2 Gy a week (overall treatment time about 8 weeks)…Three treatment … IG1 IG1 62 20 3.1 MHF 5 Moderate hypofractionation 62 Gy in 20 fractions in 5 weeks (4 fractions per week … The UHF arm was treated once a week for 5 fractions over 5 weeks to a total dose of 36.25 Gy…The PTV … Daily radiation therapy 5 times a week was delivered to the PTV in 28 fractions to a total dose of 70
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-summary.pdf
    August 01, 2023 - Executive Summary: Radiation Therapy for Metastatic Bone Disease: Effectiveness and Harms Comparative Effectiveness Review Number 265 Radiation Therapy for Metastatic Bone Disease: Effectiveness and Harms Executive Summary Main Points Background and Purpose Bone metastases are common in advan…
  16. Fraenkel (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/fraenkel.pdf
    May 29, 2025 - Four  individual bar  charts  captioned:  Infusion 1x/year;  Exercise  3x/week;  1 pill … 1x/week; none.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
    August 01, 2018 - placebo 3 RCT13-15 (n=1,047) 3 week Response Rate: Favors Cariprazine, OR 2.14 (95% CI 1.08, … A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar … Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial … followed by a 9-week double-blind trial of risperidone and haloperidol. … Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo- controlled, double-blind
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-protocol-acute-pain-treatments.pdf
    August 08, 2019 - ; 1 week to less than 2 weeks; 2 weeks to less than 4 weeks; 4 weeks or longer? … ; 1 week to <2 weeks; 2 weeks to less than 4 weeks; 4 weeks or longer? … and no treatment after followup at the following intervals: less than 1 day; 1 day to less than 1 week … ; 1 week to less than 2 weeks; 2 weeks to less than 4 weeks; 4 weeks or longer? … ; 1 week to less than 2 weeks; 2 weeks to less than 4 weeks; 4 weeks or longer?
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
    October 01, 2014 - RESULTS: Nearly 50% of the PANSS decrease was achieved by week 2 and up to 75% by week 3. … [DSM-IV]) were enrolled in a 6 week, randomized, double-blind, placebo-controlled multicenter trial ( … RCT) followed by a 26 week open-label extension study (OLE). … 1), EMBASE (1980 to 2011 Week 32), PsycINFO (1806 to August Week 2 2011), CINAHL (1937 to current), … METHODS: This study was a post-hoc analysis of pooled data from two 8-week, double-blind, randomized
  20. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
    January 28, 2016 - Additionally, Harvoni may now be used with RBV in a 12- week treatment regimen in patients with HCV … The cost of a 4-week supply of generic RBV (1,000 mg) is about $500. … The cost of a 4-week supply of IFN is about $3,500. … Daklinza/Sovaldi costs about $147,000 for a 12-week course. … The retail cost of a 12-week regimen of Viekira Pak is about $89,000;76 the retail cost of a 12-week

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: